MARKET

AGMB

AGMB

AgomAb Therapeutics NV
NASDAQ
10.85
-1.02
-8.59%
Closed 16:00 03/27 EDT
OPEN
12.00
PREV CLOSE
11.87
HIGH
12.00
LOW
10.51
VOLUME
67.75K
TURNOVER
--
52 WEEK HIGH
17.45
52 WEEK LOW
10.50
MARKET CAP
528.79M
P/E (TTM)
-4.9238
1D
5D
1M
3M
1Y
5Y
1D
Agomab receives U.S. patent for AGMB-447
TipRanks · 2d ago
AGOMAB RECEIVES U.S. PATENT FOR AGMB-447, ITS INHALED LUNG-RESTRICTED SMALL MOLECULE INHIBITOR OF ALK5 IN DEVELOPMENT FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
Reuters · 2d ago
Agomab Therapeutics receives U.S. Patent No. 12,577,230 for AGMB-447; IP protection extends through at least 2041
Reuters · 2d ago
Weekly Report: what happened at AGMB last week (0316-0320)?
Weekly Report · 5d ago
Agomab Therapeutics NV Director David R Epstein Files Initial Beneficial Ownership Statement
Reuters · 03/18 20:03
Agomab Therapeutics NV CFO Kemula Pierre Thadee Victor files Form 3 initial beneficial ownership statement
Reuters · 03/18 20:03
Agomab Therapeutics NV CEO and Director Tim Jasper Knotnerus Files Initial Beneficial Ownership Statement
Reuters · 03/18 20:03
Agomab Therapeutics NV Director Ohad Hammer files initial beneficial ownership statement
Reuters · 03/18 20:02
More
About AGMB
Agomab Therapeutics NV is a Belgium-based company. The Company is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The Company also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.

Webull offers AgomAb Therapeutics NV stock information, including NASDAQ: AGMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGMB stock methods without spending real money on the virtual paper trading platform.